Details for Patent: 9,676,525
✉ Email this page to a colleague
Which drugs does patent 9,676,525 protect, and when does it expire?
Patent 9,676,525 protects RESTASIS MULTIDOSE and is included in one NDA.
This patent has twenty-nine patent family members in twenty-six countries.
Summary for Patent: 9,676,525
| Title: | Protective cap for a dispenser, and discharge device for discharging pharmaceutical and/or cosmetical liquids |
| Abstract: | A protective cap for a dispenser for discharging liquids, wherein the dispenser has a liquid reservoir and an outlet opening through which the liquid is discharged into a surrounding atmosphere. The protective cap has an inner cap and an outer cap, the inner cap having a ventilation opening for communication between an interior of the protective cap and an external environment. Before use, the outer cap is mounted on the inner cap in a first position with the inner cap and the outer cap in sealing contact with each other and the ventilation opening is separated in an airtight and germproof manner from the environment, and the outer cap is movable relative to the inner cap from the first position to a second position in which the inner and outer caps are out of sealing contact with each other and the ventilation opening communicates with the environment. |
| Inventor(s): | Greiner-Perth; Juergen (Gottmadingen, DE), Krampen; Gerald (Radolfzell, DE), Herz; Andi (Eigeltingen-Reute, DE), Shankar; Sai (Irvine, CA), Mallare; Antonio O. (Gardena, CA) |
| Assignee: | APTAR RADOLFZELL GMBH (Radolfzell, DE) |
| Application Number: | 14/108,570 |
|
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 9,676,525
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | RESTASIS MULTIDOSE | cyclosporine | EMULSION;OPHTHALMIC | 050790-002 | Oct 27, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,676,525
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014368816 | ⤷ Try a Trial | |||
| Brazil | 112016013687 | ⤷ Try a Trial | |||
| Canada | 2933062 | ⤷ Try a Trial | |||
| China | 105813950 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
